FOXO TECHNOLOGIES INC. Deferred Federal Income Tax Expense (Benefit)
FOXO TECHNOLOGIES INC. (FOXO) reported Deferred Federal Income Tax Expense (Benefit) of -$140.54 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-04-15
- FOXO TECHNOLOGIES INC. deferred federal income tax expense (benefit) for the quarter ending 2022-06-30 was -$224.00K, a 174.67% decline year-over-year.
- FOXO TECHNOLOGIES INC. deferred federal income tax expense (benefit) for the quarter ending 2022-03-31 was -$494.00K.
- FOXO TECHNOLOGIES INC. deferred federal income tax expense (benefit) for the quarter ending 2021-12-31 was $3.53M.
- FOXO TECHNOLOGIES INC. deferred federal income tax expense (benefit) for the quarter ending 2021-09-30 was $592.00K.
- FOXO TECHNOLOGIES INC. deferred federal income tax expense (benefit) for fiscal 2025 was -$140.54K.
- FOXO TECHNOLOGIES INC. deferred federal income tax expense (benefit) for fiscal 2023 was $4.80M, a 50.83% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. deferred federal income tax expense (benefit) for fiscal 2022 was $9.77M, a 189.65% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. deferred federal income tax expense (benefit) for fiscal 2021 was $3.37M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 3 month | Deferred Federal Income Tax Expense (Benefit) 6 month | Deferred Federal Income Tax Expense (Benefit) 8 month | Deferred Federal Income Tax Expense (Benefit) 8 month as first filed | Deferred Federal Income Tax Expense (Benefit) 9 month | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$140.54K 10-K · filed 2026-04-15 | ||||||
| 2023-12-31 | $4.80M 10-K · filed 2024-06-06 | ||||||
| 2022-12-31 | $9.77M 10-K · filed 2024-06-06 | ||||||
| 2022-06-30 | -$224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$718.00K 10-Q · filed 2022-08-12 | $2.81M derived: sum of 3 quarters · filed 2023-03-31 | $3.40M derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2022-03-31 | -$494.00K 10-Q · filed 2022-05-16 | $3.04M derived: sum of 2 quarters · filed 2023-03-31 | $3.63M derived: sum of 3 quarters · filed 2023-03-31 | $3.93M derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2021-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.12M derived: sum of 2 quarters · filed 2023-03-31 | $4.42M derived: sum of 3 quarters · filed 2023-03-31 | $3.37M 10-K · filed 2023-03-31 | -$268.00K 10-K · filed 2022-03-07 | ||
| 2021-09-30 | $592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $892.00K derived: sum of 2 quarters · filed 2021-11-15 | -$158.00K 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$750.00K 10-Q · filed 2021-08-16 | |||||
| 2021-03-31 | -$1.05M 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | $375.00K 10-K/A · filed 2021-05-17 | $8.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |